Aurum Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.15 M
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.79 Cr
- Satisfied Charges ₹ 7.38 Cr
- Revenue Growth 78.88%
- Profit Growth -49.26%
- Ebitda -30.62%
- Net Worth 1.47%
- Total Assets 30.18%
About Aurum Pharmachem
Aurum Pharmachem Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 March 1998 and has a history of 26 years and ten months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.15 M.
The company currently has active open charges totaling ₹4.79 Cr. The company has closed loans amounting to ₹7.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Moti Bhura, Ankit Bhura, Jai Bothra, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232WB1998PTC086880
-
Company No.
086880
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Mar 1998
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
What products or services does Aurum Pharmachem Private Limited offer?
Aurum Pharmachem Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Speciality Chemicals.
Who are the key members and board of directors at Aurum Pharmachem?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmal Bhura
|
Director | 20-Jun-2007 | Current |
|
Jai Bothra
|
Director | 30-Mar-1998 | Current |
|
Ankit Bhura
|
Director | 02-Sep-2019 | Current |
|
Moti Bhura
|
Director | 03-Oct-2005 | Current |
Financial Performance of Aurum Pharmachem.
Aurum Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 78.88% increase. The company also saw a substantial fall in profitability, with a 49.26% decrease in profit. The company's net worth moved up by a moderate rise of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurum Pharmachem?
In 2023, Aurum Pharmachem had a promoter holding of 64.21% and a public holding of 35.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Maanek Exim Private LimitedMoti Bhura and Nirmal Bhura are mutual person
-
Preksha Residency Llp
Jai Bothra and Nirmal Bhura are mutual person
-
Aurum Chemicals Private Limited
Jai Bothra and Nirmal Bhura are mutual person
-
Panther Tie-Up Private Limited
Jai Bothra and Nirmal Bhura are mutual person
-
Tushar Pharma-Chem Pvt Ltd
Jai Bothra is a mutual person
-
Molecular Pharma Private Limited
Jai Bothra is a mutual person
Charges (Loans)
₹47.91 M
₹73.76 M
Charges Breakdown by Lending Institutions
- Others : 4.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2023 | Others | ₹4.79 Cr | Open |
| 27 Jul 2018 | Others | ₹2.80 Cr | Satisfied |
| 01 Sep 2011 | The Royal Bank Of Scotland N. V. | ₹1.50 Cr | Satisfied |
| 15 Jun 2011 | The Royal Bank Of Scotland N. V. | ₹1.50 Cr | Satisfied |
| 09 Jul 2003 | State Bank Of India | ₹9.00 M | Satisfied |
How Many Employees Work at Aurum Pharmachem?
Aurum Pharmachem has a workforce of 19 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurum Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurum Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
